10,11-Dehydrocurvularin attenuates LPS-induced neuroinflammation in BV2 cells by inhibiting the TLR2/MyD88/NLRP3 signaling pathway
{{output}}
Neuroinflammation, driven by microglial activation and Toll-like receptor 2 (TLR2) signaling, is a hallmark of neurodegenerative diseases. While 10,11-Dehydrocurvularin (DCV) is known for its anti-inflammatory properties, its specific effects on neuroinflammat... ...
